Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

NGS-Based Minimal Residual Disease (MRD) after Stem Cell Transplantation (SCT) Is More Specific for Relapse Prediction Than qPCR and Suggests the Possibility of False-Positive qPCR Results

Michaela Kotrova, MD, Vincent H.J. van der Velden, PhD, Jacques J.M. van Dongen, MD PhD, Renata Formankova, MD PhD, Petr Sedlacek, MD PhD, Monika Brüggemann, MD PhD, Jan Zuna, MD PhD, Jan Stary, MD, Jan Trka, MD PhD, Eva Fronkova, M. D., Ph. D.

Blood (2016) 128 (22): 3494.

https://doi.org/10.1182/blood.V128.22.3494.3494

Published: 2016

Journal Articles

Functional GSTA1 Haplotypes Affect Clearance and Toxicity of Busulfan When Administered in 16 Doses to Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Multicenter Prospective Study on Behalf of the Pediatric Disease Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Blood (2016) 128 (22): 665.

https://doi.org/10.1182/blood.V128.22.665.665

Published: 2016

Journal Articles

Defibrotide for Prophylaxis of Hepatic Veno-Occlusive Disease in Pediatric Hematopoietic Stem Cell Transplantation: Subanalysis Data from an Open-Label, Phase III, Randomized Trial

Selim Corbacioglu, MD, Ansgar S. Schulz, MD, Petr Sedlacek, MD PhD, Bernd Gruhn, MD, Simone Cesaro, MD, Peter Bader, MD

Blood (2015) 126 (23): 4310.

https://doi.org/10.1182/blood.V126.23.4310.4310

Published: 2015

Journal Articles

Risk Factors Affecting Outcome of Transplantation in Pediatric Acute Lymphoblastic Leukemia: Results of the International BFM ALL SCT Study

Adriana Balduzzi, MD, Jean-Hugues Dalle, MD PhD, Arjan C Lankester, MD PhD, Isaac Yaniv, MD, Akif Yesilipek, MD, Petr Sedlacek, MD PhD, Marianne Ifversen, MD, Sabina Sufliarska, MD, Marc B Bierings, MDPhD, Jacek Wachowiak, Prof MDPhD, Jacek Toporski, MD PhD, Ulrike Poetschger, Evgenia Glogova, Ingeborg Hirsch, BS, Christina Peters, MD PhD

Blood (2015) 126 (23): 2015.

https://doi.org/10.1182/blood.V126.23.2015.2015

Published: 2015

Journal Articles

Switch to Subsequent Line of Treatment in Children and Adolescents with Chronic Myeloid Leukemia (CML) Treated with Imatinib: Experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents (I-CML-Ped Study)

Frédéric Millot, Joelle Guilhot, PhD, Meinolf Suttorp, Prof. Dr., Anne Sophie Meunier, MD, Gunes Adalet Meral, MD, Petr Sedlacek, MD PhD, Eveline de Bont, MD PhD, Chi Kong Li, MD, Krzysztof Kalwak, Birgitte Lausen, Srdjana Culic, Barbara De Moerloose, MD PhD, Andrea Biondi, Prof, MD, Andre Baruchel, MD

Blood (2015) 126 (23): 1576.

https://doi.org/10.1182/blood.V126.23.1576.1576

Published: 2015

Journal Articles

Dual Production of IL-2 and IFN-Gamma by CMV-Specific CD8+ T-Cells Is a Hallmark of Their Ability to Control CMV Reactivation in Patients After Hematopoietic Stem Cell Transplantation,

Tomas Kalina, MD, PhD, Ladislav Krol, MD., Jan Stuchly, MSc., Petra Keslova, MD., Petr Hubacek, MD., Ondrej Pelak, Petr Sedlacek, MD, PhD, Jan Stary, M.D., Ondrej Hrusak, MD., PhD.

Blood (2011) 118 (21): 4081.

https://doi.org/10.1182/blood.V118.21.4081.4081

Published: 2011

Journal Articles

Chronic Myeloid Leukemia in Pediatrics — First Results From Study CML-PAED II.

Meinolf Suttorp, MD, PhD, Christian Thiede, MD, PhD, Josefine T Tauer, BS, MS, Silja Roettgers, PhD, Petr Sedlacek, MD, PhD, Jochen Harbott, PhD

Blood (2009) 114 (22): 342.

https://doi.org/10.1182/blood.V114.22.342.342

Published: 2009

Journal Articles

Minitransplant Using Repeated Unrelated Donor Lymphocyte Infusions as a Treatment of Immunodeficiency in Complete DiGeorge Syndrome.

Renata Formankova, MD, Katerina Zdrahalova, MD, Petr Sedlacek, MD, PhD, Petra Keslova, MD, Ondrej Hrusak, MD, PhD, Ester Mejstrikova, MD, Tomas Kalina, MD, Hana Zizkova, MD, Anna Sediva, MD, PhD, Jirina Bartunkova, MD, PhD, Karel Dlask, MD, Jan Stary, MD, PhD

Blood (2005) 106 (11): 5438.

https://doi.org/10.1182/blood.V106.11.5438.5438

Published: 2005

NARROW

NGS-Based Minimal Residual Disease (MRD) after Stem Cell Transplantation (SCT) Is More Specific for Relapse Prediction Than qPCR and Suggests the Possibility of False-Positive qPCR Results

Defibrotide for Prophylaxis of Hepatic Veno-Occlusive Disease in Pediatric Hematopoietic Stem Cell Transplantation: Subanalysis Data from an Open-Label, Phase III, Randomized Trial

Risk Factors Affecting Outcome of Transplantation in Pediatric Acute Lymphoblastic Leukemia: Results of the International BFM ALL SCT Study

Switch to Subsequent Line of Treatment in Children and Adolescents with Chronic Myeloid Leukemia (CML) Treated with Imatinib: Experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents (I-CML-Ped Study)

Dual Production of IL-2 and IFN-Gamma by CMV-Specific CD8+ T-Cells Is a Hallmark of Their Ability to Control CMV Reactivation in Patients After Hematopoietic Stem Cell Transplantation,

Chronic Myeloid Leukemia in Pediatrics — First Results From Study CML-PAED II.

Minitransplant Using Repeated Unrelated Donor Lymphocyte Infusions as a Treatment of Immunodeficiency in Complete DiGeorge Syndrome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only